Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,016 JPY | -0.20% | -0.64% | -7.14% |
2023 | HABA Laboratories,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2021 | HABA Laboratories,Inc.(JASDAQ:4925) dropped from S&P Global BMI Index | CI |
Sales 2022 | 12.91B 83.32M | Sales 2023 | 12.04B 77.71M | Capitalization | 8.81B 56.87M |
---|---|---|---|---|---|
Net income 2022 | -269M -1.74M | Net income 2023 | -707M -4.56M | EV / Sales 2022 | 0.39 x |
Net cash position 2022 | 3.09B 19.97M | Net cash position 2023 | 2.78B 17.98M | EV / Sales 2023 | 0.5 x |
P/E ratio 2022 |
-30.4
x | P/E ratio 2023 |
-12.5
x | Employees | 654 |
Yield 2022 |
1.85% | Yield 2023 |
1.72% | Free-Float | 56.05% |
1 day | -0.20% | ||
1 week | -0.44% | ||
Current month | -2.94% | ||
1 month | -5.13% | ||
3 months | -7.01% | ||
6 months | -12.80% | ||
Current year | -7.14% |
Managers | Title | Age | Since |
---|---|---|---|
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 13-09-30 |
Noriko Koyanagi
CHM | Chairman | 78 | 15-05-31 |
Chief Tech/Sci/R&D Officer | 59 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tsunekazu Umeda
BRD | Director/Board Member | 78 | 00-05-31 |
Noriko Koyanagi
CHM | Chairman | 78 | 15-05-31 |
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 13-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 2,016 | -0.20% | 2 500 |
24-04-23 | 2,020 | 0.00% | 1,300 |
24-04-22 | 2,020 | +0.30% | 2,200 |
24-04-19 | 2,014 | -0.35% | 3,800 |
24-04-18 | 2,021 | -0.20% | 2,500 |
Delayed Quote Japan Exchange, April 24, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-7.14% | 49.35M | |
+10.29% | 19.38B | |
0.00% | 17.44B | |
+0.35% | 10.95B | |
-5.88% | 10.46B | |
-1.93% | 6.35B | |
+8.90% | 5.89B | |
-1.12% | 4.47B | |
-8.96% | 4.2B | |
+2.58% | 3.76B |
- Stock Market
- Equities
- 4925 Stock